Table 1.
Characteristics of the survey respondents
| Pre-WASID n=181 | Post-WASID n=199 | Post-SAMMPRIS n=302 | p-value* | |||||
|---|---|---|---|---|---|---|---|---|
| Total | Total | Total | ||||||
| No. | % | No. | % | No. | % | |||
| type of practice | ||||||||
| community | 43 | 25% | 37 | 19% | 82 | 27% | 0.0431 | |
| university hospital | 108 | 64% | 145 | 76% | 195 | 65% | ||
| other | 18 | 11% | 9 | 5% | 23 | 8% | ||
| years clinical experience since training | ||||||||
| 1-2 | 1 | 1% | 5 | 3% | 35 | 12% | <0.001 | |
| 3-5 | 22 | 13% | 16 | 8% | 48 | 16% | ||
| 6-10 | 35 | 21% | 62 | 32% | 31 | 10% | ||
| 11-15** | 111 | 66% | 30 | 16% | 50 | 17% | ||
| > 15** | - | 0% | 78 | 41% | 137 | 50% | ||
| Proportion of patients in clinical practice treated for stroke | ||||||||
| 76-100% | 45 | 26% | 60 | 31% | 90 | 30% | 0.3623 | |
| 51-75% | 39 | 23% | 49 | 26% | 70 | 23% | ||
| 26-50% | 39 | 23% | 33 | 17% | 58 | 19% | ||
| 15-25% | 37 | 22% | 27 | 14% | 54 | 18% | ||
| < 15% | 10 | 6% | 22 | 12% | 28 | 9% | ||
| Participation in clinical trial | ||||||||
| WASID (yes) | 55 | 30% | 70 | 35% | 65 | 22% | 0.0026 | |
| SAMMPRIS (yes) | - | - | - | - | 110 | 36% | ||
*
Chi-square p-value comparing characteristics across the 3 surveys
**
the Pre-WASID categories were 1-2, 3-5, 6-10, and >10 years.